| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681858 | Clinical Neurology and Neurosurgery | 2018 | 27 Pages |
Abstract
LC3 may be one of the factors that affect the tumor cellular immunity response in gliomas. The simultaneous detection of LC3, CD68â¯+â¯microglia and CD8â¯+â¯T lymphocytes can be used to assess the prognosis of glioma.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Weiguo Zhang, Shuhua Wu, Ke Guo, Zhongbo Hu, Jiangtao Peng, Jianmin Li,